Please login to the form below
Clinical reports
This page shows the latest Clinical reports news and features for those working in and with pharma, biotech and healthcare.
BioMarin’s application for haemophilia A gene therapy accepted by FDA
The BLA includes data from the valoctocogene roxaparvovec clinical development programme, which the company reports is the most extensively studied gene therapy for severe haemophilia A.
Latest news
-
Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
Earlier this year, AZ refuted German media reports suggesting that the Oxford-partnered vaccine is less effective in people over the age of 65. ... In response, AZ said that the reports were 'completely incorrect', citing pre-clinical and clinical data
-
With knowledge and position comes responsibility
This includes press releases, clinical trial reports or published news articles.
-
Novartis says data backs safety of on-hold intrathecal Zolgensma
AveXis says it provided data showing it received no clinical reports of ‘sensory neuronopathy’ – which could result from DRG inflammation – in 335 patients following intravenous or intrathecal treatment with Zolgensma to ... The agency is
-
Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather pace
19. The company said it was responding to “unsubstantiated reports” saying the dug was effective, but added it was screening all its antiviral compounds for efficacy against coronaviruses. ... Annother IL-6 inhibitor – Sanofi and Regeneron’s
-
The forefront of technology innovation
2017). It postulates that the automated writing of clinical study reports will be happening as standard, using natural language processing to convert structured study data into text narratives.
More from news
Approximately 1 fully matching, plus 61 partially matching documents found.
Latest Intelligence
-
Every superhero has an origin story – what’s yours?
Therefore, it is important to engage medical communications suppliers who can effectively and efficiently translate the jargon used in technical pharmacology reports into a format where the clinical implications of ... Likewise, journal editors
-
China’s clinical trial shake-up
On paper, China offers a huge patient population that accelerates clinical trial timelines. ... Going forward, all NDAs must include clinical trial self-inspection reports, giving the system a safeguard that could deter sponsors from running substandard
-
How can pharma build bridges with HCPs online?
I go through the intranet to access our clinical systems such as CyberLab and Cyber Radiology to request tests and investigations. ... In most instances, pharma already has much medically approved, clinically relevant and compliant content at its disposal
-
LEO: Patients benefit from transparency
Clinical study reports are a critical part of the regulatory and clinical documentation so it’s really important that they are done correctly. ... We have published our clinical reports and studies for our approved products dating back to 1990.
-
Mobile health and patient outcomes
Historically the focus has been on clinical outcomes, with an assumption that this naturally aligns with the outcomes from a patient’s perspective. ... This could have an impact on clinical study endpoints, for example patient reports may contradict
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
PAN bolsters team with two hires and three promotions
abstracts, clinical reports and manuscripts; and processing data from laboratory reports.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
August 2020: diversity and inclusion in clinical trials round-up
More reports are coming to light about the lack of ethnicity reporting, and the underrepresentation of ethnic minorities. ... This research found that a third of clinical trials didn’t report race or ethnicity data.
-
'Fake news': battling misinformation in healthcare
Primary research papers and clinical trial reports are close to impenetrable". ... Unless you have a background in the field concerned, primary research papers and clinical trial reports are close to impenetrable.
-
Unlocking potential: How can pharma capitalise on its resources to support the NHS?
This content ranges from clinical evidence papers, to trials results reported in conference highlights and clinical guidelines. ... Reports from joint working initiatives that show, for example, how new treatments are changing patient pathways, could
-
A man walks into a surgery: The role of storytelling in pharma marketing
In our minds, stories are associated with childhood and with fiction, whereas we are concerned with hard facts and clinical evidence. ... Medical knowledge advances not just through clinical trials but through anecdotal reports, which are slices of life
-
CASE STUDY: Modification of CERs for a Large Orthopedic Device Company
We urgently remediated existing CERs and successfully completed over 50 high-quality CERs in 1 year. Our adaptability allows us to collaborate effectively with our clients. We focus on understanding the challenges faced by each client and offer
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
